Reports

Ideas That Generate Results

Global Biosimilar Market Outlook 2022

Global Biosimilar Market Outlook 2022

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Sep, 2016| No. of Pages : 135

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1500.00
CD-ROM Mail Delivery
US$ 1700.00
Hard Copy Mail Delivery
US$ 1700.00
Electronic Access - Multi-User License
US$ 2200.00
1. Analyst View

2. Research Methodology

3. Global Biosimilars Market Outlook 2022

4. Market Dynamics
     4.1 Drivers
            4.1.1 Growing Geriatric Population
            4.1.2 Entry of Biosimilars in the US Market
            4.1.3 Ability to Curb Healthcare Cost
            4.1.4 Rising Incidences of Chronic Diseases
            4.1.5 Government Initiatives
     4.2 Challenges
            4.2.1 Regulatory Issues
            4.2.2 Greater Litigation Risk
            4.2.3 Lack of Standardized Manufacturing Process
     4.3 Opportunities
            4.3.1 Emerging Markets - Area of Opportunities for Biosimilars
            4.3.2 Patent Expiry of Blockbuster Biologics

5. Market Segmentation by Product Type
     5.1 Erythropoietin (EPO)
     5.2 Human Growth Hormone (HGH)
     5.3 Granulocyte- Colony Stimulating Factor (G-CSF)
     5.4 Monoclonal Antibody (mAb)
     5.5 Insulin
     5.6 Interferon (IFN)
     5.7 Others

6. Market Segmentation by Geography
     6.1 Europe
            6.1.1 Germany
            6.1.2 France
            6.1.3 Italy
            6.1.4 Spain
            6.1.5 UK
     6.2 Asia-Pacific
            6.2.1 India
            6.2.2 China
            6.2.3 Japan
     6.3 North America
            6.3.1 US
            6.3.2 Canada
     6.4 Rest of the World

7. Market Segmentation by Applications
     7.1 Oncology
     7.2 Blood Disorders
     7.3 Others

8. Market Trends and Developments
     8.1 Development of Modular Biosimilar Plants
     8.2 Biosimilars in Oncology

9. Mergers and Acquisitions

10. Porter's Five Forces Analysis

11. Competitive Landscape
       11.1 Market Share of Major Players
       11.2 Company Profiles
                11.2.1 Biocad
                11.2.2 Celltrion Inc.
                11.2.3 Dong-A Socio Group
                11.2.4 Pfizer Inc.
                11.2.5 Intas Pharmaceuticals Ltd.
                11.2.6 Sandoz International GmbH - A Novartis Company
                11.2.7 Stada Arzneimittel AG
                11.2.8 Teva Pharmaceutical Industries Ltd.
                11.2.9 Amgen Inc.
                11.2.10 Biocon

12. Future Outlook
Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.